Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × COVID-19 × palbociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 119 Neoplasm Metastasis 20 Neoplasms 16 Sarcoma 10 Ovarian Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 8 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Endometrial Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Head and Neck Neoplasms 5 Sarcoma, Ewing 4 Recurrence 4 Multiple Myeloma 4 Medulloblastoma 4 Lung Neoplasms 4 Carcinoma, Renal Cell 4 Breast Diseases 4 Triple Negative Breast Neoplasms 3 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Osteosarcoma 3 Neuroblastoma 3 Liposarcoma 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3

Interventions

Standard of Care 7 Practice Guidelines as Topic 3 Hydroxychloroquine 3 Blood Specimen Collection 3 BNT162 Vaccine 3 tocilizumab 2 sotrovimab 2 cilgavimab and tixagevimab drug combination 2 Specimen Handling 2 CVnCoV COVID-19 vaccine 2 COVID-19 Vaccines 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 2019-nCoV Vaccine mRNA-1273 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 proxalutamide 1 palbociclib 1 monalizumab 1 lenzilumab 1 ciclesonide 1 bemcentinib 1 avdoralimab 1 acalabrutinib 1 XAV-19 1 Therapeutics 1 Sperm Count 1 Sodium Chloride 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05371275 2022-11-07

CDK6COV

biotx.ai GmbH

Phase 2 Withdrawn

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡